Seres' total vehicle sales in December reached 63,700 units, marking a year-on-year increase of 53.54%; the 'Shanhai‧Zhiyi Large Model' empowered Unisound to secure a regional medical cooperation contract worth over 20 million yuan.
Material Events:
Empowered by the 'Shanhai Zhiyi Large Model,' Unisound (09678) has secured a major regional healthcare cooperation contract worth over 20 million yuan.
Kelun Botai Bio-B (06990) core product TROP2 ADC Luskansatuzumab (SAC-TMT) combined with immunotherapy Pembrolizumab has received Breakthrough Therapy Designation from the NMPA for first-line treatment of PD-L1 positive locally advanced or metastatic non-small cell lung cancer.
Insilico Medicine (03696) has entered into a multi-year oncology drug research and development collaboration with Servier, valued at $888 million.
Hutchmed (00013) has initiated the Phase III stage of the ongoing study on the combination of surufatinib and camrelizumab for the treatment of previously untreated pancreatic ductal adenocarcinoma.
Ascletis Pharma-B (01672) announced that its ASC30 13-week Phase II study IND for diabetes patients has been approved by the US FDA.
Fosun Medical Technology (01696) subsidiary's reauthorized injectable botulinum toxin type A has passed quality standards inspection by the National Institutes for Food and Drug Control of China.
CanSino Biologics (06185): The 24-valent pneumococcal polysaccharide conjugate vaccine (CRM197/Tetanus Toxoid) has received clinical trial approval in China.
Shijiaoyao Group (02005): Obtained production registration approval for Perindopril Amlodipine Tablets (III) (Perindopril Arginine 10mg, Amlodipine Besylate 5mg).
Sunny Optical (02382): Proposed spin-off of automotive optics-related business for independent listing on the Main Board of the Hong Kong Stock Exchange.
Dongyangguang Pharmaceutical (06887): HECN30227 has completed enrollment of the first domestic subject.
Haitian International (01882) subsidiary plans to sell 100% equity of Guohua Machinery for RMB 342 million.
Yuexiu Property (00123) subsidiary plans to sell a total of 73.74% actual interest in Hangzhou Yueyun.
CIMC Group (02039) subsidiary CIMC Sinotrans plans to introduce strategic investors through a capital increase and the transfer of a small number of existing shares.
Operating performance:
Chifeng Gold (06693) announced an expected annual net profit attributable to shareholders of approximately RMB 3 billion to RMB 3.2 billion, representing a year-on-year increase of about 70% to 81%.
Corning Hospital (02120) is projected to have approximately 720,200 outpatient visits in the 2025 fiscal year, representing a year-on-year increase of 29%.
Seres (09927) reported total automobile sales of 63,700 units in December, marking a year-on-year increase of 53.54%.
Concord New Energy (00182) reported equity-based power generation of 790.32 GWh in December.
Country Garden (02007) reported contract sales attributable to shareholders of approximately RMB 2.69 billion in December.
